Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px
Organisation › Details

CovalX AG

CovalX is the market leader in intact protein complex analysis using high mass MALDI based technology with headquarters in Zürich, Switzerland and a North American subsidiary in Saugus, MA. CovalX also supports sales/distribution across Europe, in Japan, Korea and Russia. The technology and applications are protected by a strong patent portfolio. Target groups consist primarily of life science research laboratories and pharmaceutical and biotechnology companies worldwide. CovalX focuses on biotech analytics as the prime area for future growth. The company currently has released its third generation of high mass MALDI detection systems on the market with a range of stabilization chemistries and data analysis software for applications characterizing protein interactions. CovalX also offers a full CRO analytics service featuring all of its novel applications directly to customer. Based in Zürich, Switzerland, the company is privately held. *


Period Start 2007-06-02 renamed
  Group CovalX (Group)
  Predecessor CovalX GmbH
Products Industry MALDI-TOF mass spectrometry technology
  Industry 2 mass spectrometry services (MS services)
Region Region Schlieren ZH
  Country Switzerland
  Street 11a Grabenstr.
  City 8952 Schlieren ZH
  Tel +41-44-755-7000
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: 
Record changed: 2019-06-09


Picture Kentro Design Corporate and Web Design for Start Ups 650x80px

More documents for CovalX (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px

» top